Insider Transactions in Q1 2024 at Castle Biosciences Inc (CSTL)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 21
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
121
-0.09%
|
$2,420
$20.7 P/Share
|
|
Mar 21
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
73
-0.1%
|
$1,460
$20.7 P/Share
|
|
Mar 20
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,847
-2.77%
|
$76,940
$20.27 P/Share
|
|
Mar 20
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,295
-3.18%
|
$45,900
$20.27 P/Share
|
|
Mar 07
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,996
-2.78%
|
$79,920
$20.77 P/Share
|
|
Mar 07
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,372
-3.19%
|
$47,440
$20.77 P/Share
|
|
Mar 05
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
4,131
-5.26%
|
$86,751
$21.41 P/Share
|
|
Mar 05
2024
|
Derek J Maetzold Pres. & Chief Exec. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,686
+11.97%
|
$32,058
$3.72 P/Share
|
|
Mar 04
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
23,323
-10.5%
|
$466,460
$20.86 P/Share
|
|
Feb 07
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
2,074
-1.74%
|
$47,702
$23.2 P/Share
|
|
Feb 06
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
9,847
-7.61%
|
$226,481
$23.63 P/Share
|
|
Feb 05
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
11,402
-4.1%
|
$262,246
$23.08 P/Share
|
|
Jan 05
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
5,100
-3.48%
|
$102,000
$20.36 P/Share
|
|
Jan 04
2024
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
18,223
-11.0%
|
$364,460
$20.4 P/Share
|
|
Jan 02
2024
|
Tobin W Juvenal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,701
+6.91%
|
$13,402
$2.89 P/Share
|